Use of gastroprotective agents in recommended doses in hospitalized patients receiving NSAIDs: a drug utilization study

Author： Erdeljic Viktorija   Francetic Igor   Macolic Sarinic Viola   Bilusic Marinko   Makar Ausperger Ksenija   Huic Mirjana   Mercep Iveta  

Publisher： Springer Publishing Company

ISSN： 0928-1231

Source： Pharmacy World and Science, Vol.28, Iss.5, 2006-10, pp. : 318-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gastroprotective use low among at-risk patients using NSAIDs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 382, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Inadequate Use of Preventive Strategies in Patients Receiving NSAIDs

By Francetic I.  

Clinical Drug Investigation, Vol. 25, Iss. 4, 2005-01 ,pp. : 265-270

Adis International

Access to resources Recommend Favorite

Use of Baraclude [entecavir] is not recommended in patients with HIV/hepatitis B coinfection who are not receiving HAART

By  

Reactions Weekly, Vol. 1, Iss. 1166, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Use of Baraclude [entecavir] is not recommended in patients with HIV/hepatitis B coinfection who are not receiving HAART

By  

Inpharma, Vol. 1, Iss. 1602, 2007-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Use of exenatide and liraglutide in Denmark: a drug utilization study

By Pottegård Anton   Bjerregaard Bine   Larsen Michael   Larsen Kasper   Hallas Jesper   Knop Filip   Moreno Søren  

European Journal of Clinical Pharmacology, Vol. 70, Iss. 2, 2014-02 ,pp. : 205-214

Springer Publishing Company

Access to resources Recommend Favorite